3D bioprinting is no longer just a promise in the laboratory; it is an industrial reality used in regenerative medicine and human restoration. It is fully in line with the broader dynamic of bioconvergence, where biology, data and engineering combine to redefine healthcare standards. This quick start guide is intended for leaders who see technology as a lever for more precise, safer and more dignified medicine.
🛠️ Step 1: Calibrate the precision tool
It all starts with the equipment. Unpack the REGENHU unit, the R-GEN 200. This is not just a printer, but a 3D bioprinting system capable of maintaining mechanical precision of ±5 µm. It is this surgical precision that enables the transition from prototype to repeatable clinical solution, guaranteeing the integrity of each structure produced.
REGENHU’s R-GEN 200 platform enables high-precision 3D bioprinting. © REGENHU
🧪 Step 2: Prepare the living matrix
Open the BIO INX bottles. These are not standard inks, but high-resolution bio-inks designed for multiphoton lithography. Capable of achieving sub-cellular precision of less than 500 nm while guaranteeing 75% cell viability after one week, these materials create the environment for cells to organize themselves into functional tissues.
BIO INX’s ECM bio-inks are designed for high-resolution clinical 3D bioprinting. © BIO INX
✨ Step 3: Deploy therapeutic solutions
Activate the module corresponding to your clinical mission to transform the data into a living organ:
- Skin engineering: Follow the LabSkin Creations protocol. In just 48 hours, their technology generates multi-layered human skin models (hypodermis, dermis, epidermis). This 90% time saving compared to conventional methods drastically speeds up therapeutic validation and offers an ethical and accurate alternative to traditional testing.
- Breast restoration: Use Healshape‘s expertise. Their resorbable biopolymer which acts as a scaffold for natural regeneration, avoiding the 30-50% volume loss seen in conventional fat grafts. It is a concrete solution for restoring the physical integrity and identity of patients after a mastectomy, using their own cells.
UR SHAPE® by Healshape is a bio-printed, resorbable, bio-based breast bioprosthesis designed to promote autologous tissue regeneration after mastectomy. © Healshape
Surgical planning: Integrate Infineis solutions. By translating medical imaging into high-precision physical guides, this technology reduces positioning deviations by more than 50%. It makes surgery safer and reduces operating time by 30%, thereby optimising operating theatre efficiency.
💡 Step 4: Streamline and institutionalize
At this stage, the CEO acts as a strategic facilitator to remove regulatory and financial hurdles. The aim is to secure scaling up by transforming structural constraints into opportunities. Performance is no longer an end in itself, but the foundation that guarantees the sustainability and quality of the impact on patients.
This approach enables a transition from rapid growth to a solid structure, where long-term vision takes precedence over pure execution. As such, 3D bioprinting is establishing itself as a key infrastructure for the regenerative medicine of tomorrow.
📦 What’s in the box?
- A REGENHU clinical 3D bioprinting platform
- A set of high-resolution BIO INX bio-inks
- LabSkin Creations accelerated skin culture protocols
- Healshape autologous tissue regeneration technology
- Infineis high-fidelity surgical guidance devices
- An innovation strategy at the service of healing.
Open it and let’s bioprint!
POV: You just unboxed regenerative medicine.
